How will weight loss medications change our relationship with food?

We are now in the age of weight loss.

Decisions related to how these medications are likely to form our future health and even what our society may seem to be.

As researchers find, they already fall into the belief that obesity is simply a moral failure of the weak will.

Weight loss medications are already in the heart of the national debate. The new Labor Party government has suggested this week that it could be a tool to help people with obesity in England get rid of benefits and return to work.

This announcement – and reactions to it – has carried a mirror of our personal opinions about obesity and what should be done to address this.

Here are some of the questions that you would think of.

Is obesity something that people themselves and only need to make better life choices? Or is it a societal failed with millions of victims who need stronger laws to control the types of foods that we eat?

Are the effective weight loss medications in the obesity crisis? Are they used as a comfortable excuse to slow up the big issue that makes many people suffer from weight gain in the first place?

A personal choice against a nanny country; Ideal V – there are a few medical conditions that raise such a hot debate.

I cannot solve all these questions for you – all this depends on your personal views about obesity and the type of country you want to live. But as you think, there are some other things to consider.

Obesity is very clear, unlike conditions such as high blood pressure, and it has long been with a stain of blame and shame. Sharia is one of the seven deadly Christian sins.

Now, let’s take a look at the Semaglutide, which is sold under the name of the Wegov brand for weight loss. It mimics a hormone that is launched when we eat and deceive the brain in thinking that we are full, and we reach our appetite until we eat less.

“Suddenly your entire relationship has changed with food,” says Professor Giles Yiu, a obesity scientist at the University of Cambridge.

This has all kinds of effects on the way we think about obesity.

This also means that there are many people with weight gain, there is “a hormonal deficiency, or at least does not rise as high.”

This is a possible feature for 100 years or more when food was less abundant – which led people to consume calories when available, because there may be no tomorrow.

Our genes did not change deeply in a century, but the world in which we live made it easy to accumulate pounds with the rise of cheap and dense foods of calories, the sizes of the enlarged parts, cities and cities that make driving easier than walking or cycle.

These changes began in the second half of the twentieth century, which led to what scientists call the “obesity environment” – that is, encouraging people to eat unhealthy and not exercising sufficient exercise.

Now one in four adults in the UK are obese.

Wegovy can help people lose about 15 % of body weight starting before the Plateau Plateau.

Although it is constantly described as a “skinny drug”, it may take a person weighing 20 stone to 17 stone. Medically, this will improve health in areas such as the risk of heart attacks, sleep apnea, and type 2 diabetes.

But Dr. Margaret McCartney, GP in Glasgow, warns: “If we continue to put people in an environment of obesity, we will increase the need for these medications forever.”

Currently, NHS plans to prescribe medications for only two years due to the cost. Evidence shows That when the injection stops, the appetite returns and the weight returns.

“My big occupy is that the eye is transferred from the ball while stopping people with weight gain in the first place,” says Dr. McCartney.

We know that the obesity environment begins early. One in five Children are already overweight or are obese as they start school.

We know that it strikes poorer societies (in any 36 % of adults In England, obesity) is more difficult than the wealthy (where the number is 20 %), partly due to the lack of cheap healthy food in those richer areas.

But there is often tension between improving public health and civil freedoms. You can drive, but you have to wear a seat belt; You can smoke, but with very high taxes along with age -imposed restrictions and where you can do this.

So, here are some other things to consider. Do you think we must also treat obesity or just treat people when you start to damage their health? Should the government be more striking in the food industry, which transforms what we can buy and eat?

Should we be encouraged to go to Japanese (a country rich in low obesity) and we have smaller meals around rice, vegetables and fish? Or should we achieve calories in ready meals and chocolate bars?

What about unwanted sugar or food taxes? What about the broader ban on where you can sell or announce calories foods?

Professor Yiu says if we want to change, we will have to settle somewhere, we will have to lose some freedoms, “but” I do not think we have reached a decision within society, I do not think we discussed that. “

In England, there were official obesity strategies – 14 of them over three decades And very little to show it.

It included five campaigns a day to enhance fruits and vegetables, put food marks to highlight the caloric content, restrictions on announcing unhealthy foods for children and volunteer agreements with manufacturers to reformulate foods.

But although there are initial signs that obesity in children in England You may start to fallNone of these measures has changed the national diet enough to turn the tide to obesity in general.

There is one school thinking that weight loss medications may be even the event that leads to a change in our meals.

“Food companies win, and this is what they want – the only hope ray that I have is whether weight loss drugs help many people resist the purchase of fast foods, can this start partially reflection of the food environment?” Professor Naveed Sattar from the University of Glasgow asks.

When weight loss medications become more available, determining how to use it and how this is proportional to our broader approach to obesity, will need to be treated soon.

Currently, we only dip the fingers in the water. There is limited supplies of these drugs and because of their huge expenses, they are available on NHS for a relatively few people for a short period.

It is expected to change significantly during the next decade. New drugs, such as tirzepatide, on the way and pharmaceutical companies will lose their legal protection – patents – which means that other companies can make their own copies.

In the first days of medications or statins to lower blood pressure to reduce cholesterol, it was expensive and given to the few who would benefit more than others. Now about eight million people in the United Kingdom are taking each of these drugs.

Professor Stephen Urhli, director of the MRC metabolism unit, says blood pressure has been treated with a mixture of medications and societal change: “We have examined blood pressure, we advised to reduce sodium [salt] In foods and we have developed cheap, safe and effective blood pressure medications. “

This is similar, he says, what should happen with obesity.

It is still not clear that a number of us will end up in weight loss. Will that be only for those who suffer from obesity and medical risks? Or will it be the prevention of preventing people from obesity?

How long do people take medications to lose weight? Should it be for life? How widely used in children? Does it matter if people who use drugs still eat unhealthy food, less than them?

How quickly is weight loss medications when we still know the side effects of long -term use? Are we well with healthy people who take them completely for cosmetic reasons? Can her availability expand obesity and a healthy gap between the rich and the poor?

Many questions – but so far, some clear answers.

“I don’t know where this will descend – we are on a journey of uncertainty,” says Professor Nid Satar.

The upper image: Getty Earth

BBC It is the new home on the site and the application to get the best analysis and experience from our senior journalists. Under a distinctive new brand, we will present you with new views that challenge assumptions and deep reports on the biggest issues to help you understand a complex world. We will also view an interesting content from all over BBC Sounds and IPlayer as well. We start small but we think greatly, and we want to know what your opinion is – you can send your notes to us by clicking on the button below.